
Albert Koong, MD, PhD, becomes the new Chief Scientific Officer at UT MD Anderson Cancer Center.
Key Details
- 1Albert Koong, MD, PhD, formally appointed as UT MD Anderson's Chief Scientific Officer effective June 1, 2026.
- 2Previously served as interim CSO since January 1, 2026.
- 3Role includes overseeing laboratory and clinical research, fostering innovation, and supporting AI-driven scientific advancement.
- 4Has led as division head of Radiation Oncology and contributed significantly to GI radiation oncology research.
- 5Recognized with honors such as Fellow of the American College of Radiology (FACR) and American Society for Radiation Oncology (FASTRO).
Why It Matters

Source
EurekAlert
Related News

AI Framework Accelerates Aortic Aneurysm Risk Prediction from Imaging
Researchers developed BioPINN-LM, combining physics-informed neural networks and multimodal large language models to deliver fast, interpretable risk assessments for ascending thoracic aortic aneurysms.

Study Finds Patient Voices Missing in Generative AI Design for Oncology
A Flinders University-led review found patients and carers are rarely involved in shaping generative AI tools used in oncology.

Scripps Researchers Develop AI Foundation Model for ECG-Based Heart Disease Prediction
A new AI foundation model, ECG-CLIP, improves detection and prediction of multiple heart diseases using large-scale ECG and clinician note data.